Access to Zolgensma Survey and Submission Sent to NICE

08 August 2019

Thank you to those of you who responded to our survey asking for your views on access to the treatment Zolgensma for infants with SMA Type 1. We passed them on to MDUK and TreatSMA and used them in the submission we made jointly with MDUK. NICE is considering whether to recommend that NHS Endland funds access. 

You can see the survey results here and read the submission here.